N/A
N=23
Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke.
Stroke · CVA · Hemiplegia · Hemiparesis · Foot Drop
Bottom Line
View on ClinicalTrials.gov: NCT02693834 ↗Enrolled (actual)
23
Serious AEs
2.2%
Results posted
Feb 2020
Primary outcome: Primary: Gait Endurance — 203.44; 195.15 Meter — p=.293
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Posterior Leaf spring AFO (Device); Double adjustable AFO (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Texas Woman's University
- Primary completion
- Apr 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Gait Endurance |
255.07; 235.53 | 0.077 |
| PRIMARY Gait Endurance |
255.07; 235.53 | 0.077 |
| SECONDARY Gait Symmetry |
1.16; 1.18; 1.12; 1.10; 1.18; 1.22 | .688 |
| SECONDARY Gait Velocity SSV and FPV |
0.58; 0.58; 0.70; 0.66; 0.80; 0.78 | .209 |
Summary
PURPOSE: The purpose of this study will be to identify whether patients in the subacute stage of stroke, who demonstrate foot drop, will have better gait outcomes when using a Double Adjustable AFO, or a Posterior Leaf Spring AFO. A secondary purpose will be to determine whether one week of practice significantly changes gait outcomes with either of the AFO conditions.
INCLUSION CRITERIA: Twenty participants over the age of 18, of any gender and ethnicity, diagnosed with first time unilateral stroke, 4 - 20 weeks post-stroke onset, resulting in hemiparesis with foot drop will be recruited for this study.
EXCLUSION CRITERIA:
1. Not able to receive a double adjustable AFO through their insurance
2. Unable to follow two steps commands
3. Unable to ambulate 20 feet with or without assistive device with a minimum level of assistance of contact guard assistance.
4. Cerebellar Stroke
5. Inability to ambulate prior to stroke
6. receiving chemotherapy at the time of study
OUTCOME MEASURES:
1. Six Minute walk test
2. Gait Symmetry and Gait velocity measured with GAITRite for self paced velocity walk and fast paced velocity walk.
DATA COLLECTION:
Data will be collected three times over two weeks period.
First Visit:
Demographics, Fugl-Meyer Lower Extremity Assessment of sensorimotor function, Mini Mental State Examination 6MWT and GAITRite measurements using Both types of AFO in a random order. Afterwards participant will be given one type of AFO (randomly selected) to practice walking for a week.
Second Visit: 6MWT and GAITRite measurements using the type of AFO they were practicing with. Then the other type of AFO will be given to practice walking for a week.
Third Visit: 6MWT and GAITRite measurements using the second type of AFO that they were practicing with the week prior. Patient will be asked which type of AFO they prefer to use.
Eligibility Criteria
Inclusion Criteria
- Diagnosed with first time unilateral stroke
- 4 - 20 weeks post-stroke onset
- resulting in hemiparesis with foot drop
Exclusion Criteria
- Inability to receive a double adjustable AFO through their insurance
- unable to follow two steps commands
- unable to ambulate 20 feet with or without assistive device with a minimum level of assistance of contact guard assistance
- diagnosis of cerebellar stroke
- non ambulatory prior to stroke onset
Data sourced from ClinicalTrials.gov (NCT02693834). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.